Global Psilocybin Market Growth 2026-2032

September 2026 | 90 pages | ID: G7E3F827E05BEN
LP Information

Abstracts

The global Psilocybin market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Psilocybin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Psilocybin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Psilocybin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Psilocybin players cover Compass Pathways, TRYP Therapeutics, Cortexa, ATAI, Octarine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Psilocybin Industry Forecast” looks at past sales and reviews total world Psilocybin sales in 2025, providing a comprehensive analysis by region and market sector of projected Psilocybin sales for 2026 through 2032. With Psilocybin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psilocybin industry.

This Insight Report provides a comprehensive analysis of the global Psilocybin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psilocybin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psilocybin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psilocybin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psilocybin.

This report presents a comprehensive overview, market shares, and growth opportunities of Psilocybin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Chemical Synthesis
• Fermentation Method

Segmentation by Application:

• Depression
• Anxiety Disorders
• Obsessive-Compulsive Disorder
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Compass Pathways
• TRYP Therapeutics
• Cortexa
• ATAI
• Octarine
• MindMed

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Psilocybin market?
• What factors are driving Psilocybin market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Psilocybin market opportunities vary by end market size?
• How does Psilocybin break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Psilocybin Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Psilocybin by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Psilocybin by Country/Region, 2021, 2025 & 2032
  2.2 Psilocybin Segment by Type
  2.2.1 Chemical Synthesis
  2.2.2 Fermentation Method
  2.2.3 Psilocybin Sales by Type
  2.2.3.1 Global Psilocybin Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Psilocybin Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Psilocybin Sale Price by Type (2021-2026)
  2.3 Psilocybin Segment by Application
  2.3.1 Depression
  2.3.2 Anxiety Disorders
  2.3.3 Obsessive-Compulsive Disorder
  2.3.4 Other
  2.3.5 Psilocybin Sales by Application
  2.3.5.1 Global Psilocybin Sale Market Share by Application (2021-2026)
  2.3.5.2 Global Psilocybin Revenue and Market Share by Application (2021-2026)
  2.3.5.3 Global Psilocybin Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Psilocybin Breakdown Data by Company
  3.1.1 Global Psilocybin Annual Sales by Company (2021-2026)
  3.1.2 Global Psilocybin Sales Market Share by Company (2021-2026)
  3.2 Global Psilocybin Annual Revenue by Company (2021-2026)
  3.2.1 Global Psilocybin Revenue by Company (2021-2026)
  3.2.2 Global Psilocybin Revenue Market Share by Company (2021-2026)
  3.3 Global Psilocybin Sale Price by Company
  3.4 Key Manufacturers Psilocybin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Psilocybin Product Location Distribution
  3.4.2 Players Psilocybin Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PSILOCYBIN BY GEOGRAPHIC REGION

  4.1 World Historic Psilocybin Market Size by Geographic Region (2021-2026)
  4.1.1 Global Psilocybin Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Psilocybin Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Psilocybin Market Size by Country/Region (2021-2026)
  4.2.1 Global Psilocybin Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Psilocybin Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Psilocybin Sales Growth
  4.4 APAC Psilocybin Sales Growth
  4.5 Europe Psilocybin Sales Growth
  4.6 Middle East & Africa Psilocybin Sales Growth

5 AMERICAS

  5.1 Americas Psilocybin Sales by Country
  5.1.1 Americas Psilocybin Sales by Country (2021-2026)
  5.1.2 Americas Psilocybin Revenue by Country (2021-2026)
  5.2 Americas Psilocybin Sales by Type (2021-2026)
  5.3 Americas Psilocybin Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Psilocybin Sales by Region
  6.1.1 APAC Psilocybin Sales by Region (2021-2026)
  6.1.2 APAC Psilocybin Revenue by Region (2021-2026)
  6.2 APAC Psilocybin Sales by Type (2021-2026)
  6.3 APAC Psilocybin Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Psilocybin by Country
  7.1.1 Europe Psilocybin Sales by Country (2021-2026)
  7.1.2 Europe Psilocybin Revenue by Country (2021-2026)
  7.2 Europe Psilocybin Sales by Type (2021-2026)
  7.3 Europe Psilocybin Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Psilocybin by Country
  8.1.1 Middle East & Africa Psilocybin Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Psilocybin Revenue by Country (2021-2026)
  8.2 Middle East & Africa Psilocybin Sales by Type (2021-2026)
  8.3 Middle East & Africa Psilocybin Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Psilocybin
  10.3 Manufacturing Process Analysis of Psilocybin
  10.4 Industry Chain Structure of Psilocybin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Psilocybin Distributors
  11.3 Psilocybin Customer

12 WORLD FORECAST REVIEW FOR PSILOCYBIN BY GEOGRAPHIC REGION

  12.1 Global Psilocybin Market Size Forecast by Region
  12.1.1 Global Psilocybin Forecast by Region (2027-2032)
  12.1.2 Global Psilocybin Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Psilocybin Forecast by Type (2027-2032)
  12.7 Global Psilocybin Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Compass Pathways
  13.1.1 Compass Pathways Company Information
  13.1.2 Compass Pathways Psilocybin Product Portfolios and Specifications
  13.1.3 Compass Pathways Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Compass Pathways Main Business Overview
  13.1.5 Compass Pathways Latest Developments
  13.2 TRYP Therapeutics
  13.2.1 TRYP Therapeutics Company Information
  13.2.2 TRYP Therapeutics Psilocybin Product Portfolios and Specifications
  13.2.3 TRYP Therapeutics Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 TRYP Therapeutics Main Business Overview
  13.2.5 TRYP Therapeutics Latest Developments
  13.3 Cortexa
  13.3.1 Cortexa Company Information
  13.3.2 Cortexa Psilocybin Product Portfolios and Specifications
  13.3.3 Cortexa Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Cortexa Main Business Overview
  13.3.5 Cortexa Latest Developments
  13.4 ATAI
  13.4.1 ATAI Company Information
  13.4.2 ATAI Psilocybin Product Portfolios and Specifications
  13.4.3 ATAI Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 ATAI Main Business Overview
  13.4.5 ATAI Latest Developments
  13.5 Octarine
  13.5.1 Octarine Company Information
  13.5.2 Octarine Psilocybin Product Portfolios and Specifications
  13.5.3 Octarine Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Octarine Main Business Overview
  13.5.5 Octarine Latest Developments
  13.6 MindMed
  13.6.1 MindMed Company Information
  13.6.2 MindMed Psilocybin Product Portfolios and Specifications
  13.6.3 MindMed Psilocybin Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 MindMed Main Business Overview
  13.6.5 MindMed Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Psilocybin Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Psilocybin Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemical Synthesis
Table 4. Major Players of Fermentation Method
Table 5. Global Psilocybin Sales by Type (2021-2026) & (K Units)
Table 6. Global Psilocybin Sales Market Share by Type (2021-2026)
Table 7. Global Psilocybin Revenue by Type (2021-2026) & ($ million)
Table 8. Global Psilocybin Revenue Market Share by Type (2021-2026)
Table 9. Global Psilocybin Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Psilocybin Sale by Application (2021-2026) & (K Units)
Table 11. Global Psilocybin Sale Market Share by Application (2021-2026)
Table 12. Global Psilocybin Revenue by Application (2021-2026) & ($ million)
Table 13. Global Psilocybin Revenue Market Share by Application (2021-2026)
Table 14. Global Psilocybin Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Psilocybin Sales by Company (2021-2026) & (K Units)
Table 16. Global Psilocybin Sales Market Share by Company (2021-2026)
Table 17. Global Psilocybin Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Psilocybin Revenue Market Share by Company (2021-2026)
Table 19. Global Psilocybin Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Psilocybin Producing Area Distribution and Sales Area
Table 21. Players Psilocybin Products Offered
Table 22. Psilocybin Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Psilocybin Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Psilocybin Sales Market Share Geographic Region (2021-2026)
Table 27. Global Psilocybin Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Psilocybin Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Psilocybin Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Psilocybin Sales Market Share by Country/Region (2021-2026)
Table 31. Global Psilocybin Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Psilocybin Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Psilocybin Sales by Country (2021-2026) & (K Units)
Table 34. Americas Psilocybin Sales Market Share by Country (2021-2026)
Table 35. Americas Psilocybin Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Psilocybin Sales by Type (2021-2026) & (K Units)
Table 37. Americas Psilocybin Sales by Application (2021-2026) & (K Units)
Table 38. APAC Psilocybin Sales by Region (2021-2026) & (K Units)
Table 39. APAC Psilocybin Sales Market Share by Region (2021-2026)
Table 40. APAC Psilocybin Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Psilocybin Sales by Type (2021-2026) & (K Units)
Table 42. APAC Psilocybin Sales by Application (2021-2026) & (K Units)
Table 43. Europe Psilocybin Sales by Country (2021-2026) & (K Units)
Table 44. Europe Psilocybin Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Psilocybin Sales by Type (2021-2026) & (K Units)
Table 46. Europe Psilocybin Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Psilocybin Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Psilocybin Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Psilocybin Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Psilocybin Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Psilocybin
Table 52. Key Market Challenges & Risks of Psilocybin
Table 53. Key Industry Trends of Psilocybin
Table 54. Psilocybin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Psilocybin Distributors List
Table 57. Psilocybin Customer List
Table 58. Global Psilocybin Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Psilocybin Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Psilocybin Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Psilocybin Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Psilocybin Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Psilocybin Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Psilocybin Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Psilocybin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Psilocybin Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Psilocybin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Psilocybin Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Psilocybin Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Psilocybin Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Psilocybin Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Compass Pathways Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 73. Compass Pathways Psilocybin Product Portfolios and Specifications
Table 74. Compass Pathways Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Compass Pathways Main Business
Table 76. Compass Pathways Latest Developments
Table 77. TRYP Therapeutics Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 78. TRYP Therapeutics Psilocybin Product Portfolios and Specifications
Table 79. TRYP Therapeutics Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. TRYP Therapeutics Main Business
Table 81. TRYP Therapeutics Latest Developments
Table 82. Cortexa Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 83. Cortexa Psilocybin Product Portfolios and Specifications
Table 84. Cortexa Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cortexa Main Business
Table 86. Cortexa Latest Developments
Table 87. ATAI Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 88. ATAI Psilocybin Product Portfolios and Specifications
Table 89. ATAI Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. ATAI Main Business
Table 91. ATAI Latest Developments
Table 92. Octarine Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 93. Octarine Psilocybin Product Portfolios and Specifications
Table 94. Octarine Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Octarine Main Business
Table 96. Octarine Latest Developments
Table 97. MindMed Basic Information, Psilocybin Manufacturing Base, Sales Area and Its Competitors
Table 98. MindMed Psilocybin Product Portfolios and Specifications
Table 99. MindMed Psilocybin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. MindMed Main Business
Table 101. MindMed Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Psilocybin
Figure 2. Psilocybin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psilocybin Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Psilocybin Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Psilocybin Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Psilocybin Sales Market Share by Country/Region (2025)
Figure 10. Psilocybin Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Chemical Synthesis
Figure 12. Product Picture of Fermentation Method
Figure 13. Global Psilocybin Sales Market Share by Type in 2026
Figure 14. Global Psilocybin Revenue Market Share by Type (2021-2026)
Figure 15. Psilocybin Consumed in Depression
Figure 16. Global Psilocybin Market: Depression (2021-2026) & (K Units)
Figure 17. Psilocybin Consumed in Anxiety Disorders
Figure 18. Global Psilocybin Market: Anxiety Disorders (2021-2026) & (K Units)
Figure 19. Psilocybin Consumed in Obsessive-Compulsive Disorder
Figure 20. Global Psilocybin Market: Obsessive-Compulsive Disorder (2021-2026) & (K Units)
Figure 21. Psilocybin Consumed in Other
Figure 22. Global Psilocybin Market: Other (2021-2026) & (K Units)
Figure 23. Global Psilocybin Sale Market Share by Application (2025)
Figure 24. Global Psilocybin Revenue Market Share by Application in 2026
Figure 25. Psilocybin Sales by Company in 2026 (K Units)
Figure 26. Global Psilocybin Sales Market Share by Company in 2026
Figure 27. Psilocybin Revenue by Company in 2026 ($ millions)
Figure 28. Global Psilocybin Revenue Market Share by Company in 2026
Figure 29. Global Psilocybin Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Psilocybin Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Psilocybin Sales 2021-2026 (K Units)
Figure 32. Americas Psilocybin Revenue 2021-2026 ($ millions)
Figure 33. APAC Psilocybin Sales 2021-2026 (K Units)
Figure 34. APAC Psilocybin Revenue 2021-2026 ($ millions)
Figure 35. Europe Psilocybin Sales 2021-2026 (K Units)
Figure 36. Europe Psilocybin Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Psilocybin Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Psilocybin Revenue 2021-2026 ($ millions)
Figure 39. Americas Psilocybin Sales Market Share by Country in 2026
Figure 40. Americas Psilocybin Revenue Market Share by Country (2021-2026)
Figure 41. Americas Psilocybin Sales Market Share by Type (2021-2026)
Figure 42. Americas Psilocybin Sales Market Share by Application (2021-2026)
Figure 43. United States Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Psilocybin Sales Market Share by Region in 2026
Figure 48. APAC Psilocybin Revenue Market Share by Region (2021-2026)
Figure 49. APAC Psilocybin Sales Market Share by Type (2021-2026)
Figure 50. APAC Psilocybin Sales Market Share by Application (2021-2026)
Figure 51. China Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 55. India Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Psilocybin Sales Market Share by Country in 2026
Figure 59. Europe Psilocybin Revenue Market Share by Country (2021-2026)
Figure 60. Europe Psilocybin Sales Market Share by Type (2021-2026)
Figure 61. Europe Psilocybin Sales Market Share by Application (2021-2026)
Figure 62. Germany Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 63. France Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Psilocybin Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Psilocybin Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Psilocybin Sales Market Share by Application (2021-2026)
Figure 70. Egypt Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Psilocybin Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Psilocybin in 2026
Figure 76. Manufacturing Process Analysis of Psilocybin
Figure 77. Industry Chain Structure of Psilocybin
Figure 78. Channels of Distribution
Figure 79. Global Psilocybin Sales Market Forecast by Region (2027-2032)
Figure 80. Global Psilocybin Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Psilocybin Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Psilocybin Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Psilocybin Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Psilocybin Revenue Market Share Forecast by Application (2027-2032)